West Pharmaceutical Services (WST) Given News Impact Rating of 0.13

Press coverage about West Pharmaceutical Services (NYSE:WST) has been trending somewhat positive this week, according to Accern Sentiment. Accern identifies negative and positive news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. West Pharmaceutical Services earned a coverage optimism score of 0.13 on Accern’s scale. Accern also assigned news headlines about the medical instruments supplier an impact score of 47.3482804293243 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Here are some of the headlines that may have impacted Accern Sentiment Analysis’s analysis:

Several analysts recently issued reports on WST shares. Zacks Investment Research cut shares of West Pharmaceutical Services from a “hold” rating to a “sell” rating in a research note on Wednesday, July 19th. BidaskClub cut shares of West Pharmaceutical Services from a “hold” rating to a “sell” rating in a research note on Thursday, July 27th. Jefferies Group LLC raised shares of West Pharmaceutical Services from a “hold” rating to a “buy” rating and upped their price objective for the company from $96.00 to $115.00 in a research note on Friday, September 15th. Stephens began coverage on shares of West Pharmaceutical Services in a report on Tuesday, October 3rd. They issued an “equal weight” rating and a $99.00 target price on the stock. Finally, Bank of America Corporation lowered shares of West Pharmaceutical Services from a “buy” rating to a “neutral” rating and set a $98.00 target price on the stock. in a report on Tuesday, October 17th. One analyst has rated the stock with a sell rating, three have given a hold rating and three have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $106.00.

Shares of West Pharmaceutical Services (NYSE:WST) traded up $0.22 during mid-day trading on Monday, hitting $101.65. 252,600 shares of the stock traded hands, compared to its average volume of 367,288. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.87 and a current ratio of 2.59. West Pharmaceutical Services has a 52-week low of $76.87 and a 52-week high of $103.36. The firm has a market cap of $7,547.81, a price-to-earnings ratio of 43.81, a P/E/G ratio of 2.17 and a beta of 1.14.

West Pharmaceutical Services (NYSE:WST) last issued its quarterly earnings data on Thursday, October 26th. The medical instruments supplier reported $0.67 EPS for the quarter, topping the consensus estimate of $0.53 by $0.14. West Pharmaceutical Services had a net margin of 12.12% and a return on equity of 14.47%. The firm had revenue of $398.20 million for the quarter, compared to analyst estimates of $386.02 million. During the same period in the prior year, the business posted $0.53 EPS. The business’s revenue for the quarter was up 5.7% compared to the same quarter last year. analysts forecast that West Pharmaceutical Services will post 2.76 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This piece of content was posted by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are viewing this piece of content on another publication, it was stolen and republished in violation of US & international copyright & trademark law. The original version of this piece of content can be viewed at https://www.chaffeybreeze.com/2017/11/13/west-pharmaceutical-services-wst-given-news-impact-rating-of-0-13.html.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.

Insider Buying and Selling by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply